Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
575 | 14274 | 31.8 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
575 | 2 | VANCOMYCIN//LINEZOLID//DAPTOMYCIN | 14274 |
176 | 1 | ENTEROCOCCUS//ENTEROCOCCI//ENTEROCOCCUS FAECIUM | 4022 |
2737 | 1 | DAPTOMYCIN//HVISA//VANCOMYCIN | 2161 |
5145 | 1 | VANCOMYCIN//TEICOPLANIN//RED MAN SYNDROME | 1665 |
6235 | 1 | LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE | 1510 |
6390 | 1 | TELITHROMYCIN//KETOLIDE//MACROLIDE RESISTANCE | 1491 |
7142 | 1 | GLYCOPEPTIDE ANTIBIOTICS//RA VII//BALHIMYCIN | 1401 |
11854 | 1 | TELAVANCIN//CEFTAROLINE//LIPOGLYCOPEPTIDE | 949 |
18319 | 1 | TN916//CONJUGATIVE TRANSPOSON//NWFIII MIKROBIOL | 556 |
21421 | 1 | STREPTOGRAMIN//QUINUPRISTIN DALFOPRISTIN//DALFOPRISTIN | 419 |
35270 | 1 | EVERNINOMICIN//EVERNIMICIN//ZIRACIN | 100 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VANCOMYCIN | authKW | 1183043 | 8% | 49% | 1135 |
2 | LINEZOLID | authKW | 935780 | 4% | 69% | 631 |
3 | DAPTOMYCIN | authKW | 649792 | 3% | 75% | 406 |
4 | ENTEROCOCCUS | authKW | 359123 | 3% | 46% | 365 |
5 | ENTEROCOCCI | authKW | 354850 | 3% | 45% | 373 |
6 | TEICOPLANIN | authKW | 342784 | 2% | 57% | 283 |
7 | VANCOMYCIN RESISTANT ENTEROCOCCI | authKW | 334124 | 1% | 74% | 210 |
8 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | journal | 287243 | 12% | 8% | 1783 |
9 | VANCOMYCIN RESISTANCE | authKW | 261471 | 1% | 77% | 158 |
10 | ENTEROCOCCUS FAECIUM | authKW | 229411 | 2% | 45% | 240 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 212319 | 51% | 1% | 7235 |
2 | Infectious Diseases | 143910 | 30% | 2% | 4296 |
3 | Pharmacology & Pharmacy | 52777 | 36% | 1% | 5186 |
4 | Immunology | 2710 | 8% | 0% | 1199 |
5 | Biotechnology & Applied Microbiology | 1049 | 5% | 0% | 735 |
6 | Chemistry, Medicinal | 885 | 3% | 0% | 445 |
7 | Chemistry, Organic | 516 | 4% | 0% | 638 |
8 | Medicine, General & Internal | 442 | 4% | 0% | 625 |
9 | Medical Laboratory Technology | 300 | 1% | 0% | 146 |
10 | Critical Care Medicine | 120 | 1% | 0% | 133 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STUDY EMERGING REEMERGING PATHOGENS | 102721 | 1% | 55% | 88 |
2 | ANTIINFECT | 100418 | 1% | 41% | 116 |
3 | MOL GENET ANTIMICROBIAL ISTANCE UNIT | 74546 | 0% | 81% | 43 |
4 | UNITE AGENTS ANTIBACTERIENS | 64541 | 1% | 40% | 76 |
5 | INFECT DIS | 57846 | 10% | 2% | 1462 |
6 | EUGENE PLEBAUM PHARM HLTH SCI | 38420 | 1% | 17% | 104 |
7 | WERNIGERODE BRANCH | 32763 | 0% | 30% | 52 |
8 | MICROBIOL SERV | 25379 | 2% | 5% | 230 |
9 | MICROBIOL | 24134 | 9% | 1% | 1318 |
10 | AREA BIOQUIM BIOL MOL | 23432 | 0% | 20% | 54 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 287243 | 12% | 8% | 1783 |
2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 142987 | 6% | 7% | 916 |
3 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 72799 | 3% | 9% | 362 |
4 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 45448 | 2% | 6% | 338 |
5 | MICROBIAL DRUG RESISTANCE | 33019 | 1% | 12% | 134 |
6 | CLINICAL MICROBIOLOGY AND INFECTION | 19717 | 1% | 5% | 195 |
7 | JOURNAL OF CLINICAL MICROBIOLOGY | 17088 | 3% | 2% | 469 |
8 | CLINICAL INFECTIOUS DISEASES | 16254 | 2% | 2% | 317 |
9 | JOURNAL OF ANTIBIOTICS | 14915 | 2% | 3% | 218 |
10 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 14810 | 1% | 3% | 211 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VANCOMYCIN | 1183043 | 8% | 49% | 1135 | Search VANCOMYCIN | Search VANCOMYCIN |
2 | LINEZOLID | 935780 | 4% | 69% | 631 | Search LINEZOLID | Search LINEZOLID |
3 | DAPTOMYCIN | 649792 | 3% | 75% | 406 | Search DAPTOMYCIN | Search DAPTOMYCIN |
4 | ENTEROCOCCUS | 359123 | 3% | 46% | 365 | Search ENTEROCOCCUS | Search ENTEROCOCCUS |
5 | ENTEROCOCCI | 354850 | 3% | 45% | 373 | Search ENTEROCOCCI | Search ENTEROCOCCI |
6 | TEICOPLANIN | 342784 | 2% | 57% | 283 | Search TEICOPLANIN | Search TEICOPLANIN |
7 | VANCOMYCIN RESISTANT ENTEROCOCCI | 334124 | 1% | 74% | 210 | Search VANCOMYCIN+RESISTANT+ENTEROCOCCI | Search VANCOMYCIN+RESISTANT+ENTEROCOCCI |
8 | VANCOMYCIN RESISTANCE | 261471 | 1% | 77% | 158 | Search VANCOMYCIN+RESISTANCE | Search VANCOMYCIN+RESISTANCE |
9 | ENTEROCOCCUS FAECIUM | 229411 | 2% | 45% | 240 | Search ENTEROCOCCUS+FAECIUM | Search ENTEROCOCCUS+FAECIUM |
10 | VRE | 227609 | 1% | 60% | 177 | Search VRE | Search VRE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOWDEN, BP , DAVIES, JK , JOHNSON, PDR , STINEAR, TP , GRAYSON, ML , (2010) REDUCED VANCOMYCIN SUSCEPTIBILITY IN STAPHYLOCOCCUS AUREUS, INCLUDING VANCOMYCIN-INTERMEDIATE AND HETEROGENEOUS VANCOMYCIN-INTERMEDIATE STRAINS: RESISTANCE MECHANISMS, LABORATORY DETECTION, AND CLINICAL IMPLICATIONS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 23. ISSUE 1. P. 99-+ | 230 | 67% | 312 |
2 | NICOLAOU, KC , BODDY, CNC , BRASE, S , WINSSINGER, N , (1999) CHEMISTRY, BIOLOGY, AND MEDICINE OF THE GLYCOPEPTIDE ANTIBIOTICS.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 38. ISSUE 15. P. 2096 -2152 | 242 | 70% | 508 |
3 | WERNER, G , COQUE, TM , FRANZ, CMAP , GROHMANN, E , HEGSTAD, K , JENSEN, L , VAN SCHAIK, W , WEAVER, K , (2013) ANTIBIOTIC RESISTANT ENTEROCOCCI-TALES OF A DRUG RESISTANCE GENE TRAFFICKER.INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. VOL. 303. ISSUE 6-7. P. 360-379 | 205 | 76% | 21 |
4 | FREITAS, AR , TEDIM, AP , FRANCIA, MV , JENSEN, LB , NOVAIS, C , PEIXE, L , SANCHEZ-VALENZUELA, A , SUNDSFJORD, A , HEGSTAD, K , WERNER, G , ET AL (2016) MULTILEVEL POPULATION GENETIC ANALYSIS OF VANA AND VANB ENTEROCOCCUS FAECIUM CAUSING NOSOCOMIAL OUTBREAKS IN 27 COUNTRIES (1986-2012).JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 71. ISSUE 12. P. 3351 -3366 | 150 | 97% | 1 |
5 | ARIAS, CA , MURRAY, BE , (2012) THE RISE OF THE ENTEROCOCCUS: BEYOND VANCOMYCIN RESISTANCE.NATURE REVIEWS MICROBIOLOGY. VOL. 10. ISSUE 4. P. 266 -278 | 113 | 80% | 258 |
6 | HUMPHRIES, RM , POLLETT, S , SAKOULAS, G , (2013) A CURRENT PERSPECTIVE ON DAPTOMYCIN FOR THE CLINICAL MICROBIOLOGIST.CLINICAL MICROBIOLOGY REVIEWS. VOL. 26. ISSUE 4. P. 759-780 | 156 | 82% | 48 |
7 | CETINKAYA, Y , FALK, P , MAYHALL, CG , (2000) VANCOMYCIN-RESISTANT ENTEROCOCCI.CLINICAL MICROBIOLOGY REVIEWS. VOL. 13. ISSUE 4. P. 686 -+ | 173 | 87% | 431 |
8 | HOLMES, NE , TONG, SYC , DAVIS, JS , VAN HAL, SJ , (2015) TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: VANCOMYCIN AND BEYOND.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 36. ISSUE 1. P. 17 -30 | 140 | 89% | 11 |
9 | TAMMA, PD , HSU, AJ , (2014) OPTIMIZING THERAPY FOR VANCOMYCIN-RESISTANT ENTEROCOCCAL BACTEREMIA IN CHILDREN.CURRENT OPINION IN INFECTIOUS DISEASES. VOL. 27. ISSUE 6. P. 517 -527 | 149 | 96% | 2 |
10 | BUTLER, MS , HANSFORD, KA , BLASKOVICH, MA , HALAI, R , COOPER, MA , (2014) GLYCOPEPTIDE ANTIBIOTICS: BACK TO THE FUTURE.JOURNAL OF ANTIBIOTICS. VOL. 67. ISSUE 9. P. 631 -644 | 133 | 84% | 33 |
Classes with closest relation at Level 2 |